XML 45 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Operations (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 6 Months Ended 280 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2014
Revenue         $ 3,166
Operating expenses:          
Research and development 37,323 27,052 63,506 53,450 1,640,798
General and administrative 32,523 14,533 47,752 24,572 533,138
In-process research and development costs         19,726
Goodwill impairment         151,428
Total operating expenses 69,846 41,585 111,258 78,022 2,345,090
Loss from operations (69,846) (41,585) (111,258) (78,022) (2,341,924)
Other income (expense) (370) 15 (6,260) 38 (9,162)
Interest expense on note payable to principal stockholder (721) (1,689) (1,435) (3,378) (46,569)
Interest expense on notes (2,429) (2,866) (6,471) (5,729) (61,557)
Interest income 1 1 2 2 37,006
Loss before benefit for income taxes (73,365) (46,124) (125,422) (87,089) (2,422,206)
Income tax benefit         382
Net loss (73,365) (46,124) (125,422) (87,089) (2,421,824)
Deemed dividend related to beneficial conversion feature of convertible preferred stock         (22,260)
Accretion on redeemable preferred stock         (952)
Net loss applicable to common stockholders $ (73,365) $ (46,124) $ (125,422) $ (87,089) $ (2,445,036)
Net loss per share applicable to common stockholders - basic and diluted $ (0.19) $ (0.16) $ (0.33) $ (0.31)  
Shares used to compute basic and diluted net loss per share applicable to common stockholders 380,770 284,044 374,810 282,062